Skip to main content

What the label lists and what reports show

Terbutaline side effects

Terbutaline's FDA label lists its adverse reactions in its own words. FAERS holds 1,823 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is dyspnoea (423 reports).

  • Generic listed
  • Boxed warning

Check it at the source: the terbutaline FDA label on DailyMed (effective November 15, 2019, ANI Pharmaceuticals, Inc.); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Adverse reactions observed with terbutaline sulfate are similar to those commonly seen with other sympathomimetic amines. All of these reactions are generally transient in nature and usually do not require treatment. The frequency of these side effects appears to diminish with continued therapy. The following table lists the adverse reactions seen in 199 patients treated with terbutaline sulfate tablets during six double-blind crossover studies and four double-blind parallel studies (short- and long-term) performed in the United States. …

A table the label prints in its adverse reactions section without a title; its column headings name the groups compared

ReactionPercent Incidence of Adverse Reactions (Total Daily Dosage Range 5 to 15 mg) Terbutaline… % Nervous System
Nervousness35.0
Tremor15.0
Somnolence5.5
Dizziness3.5
Anxiety1.0
Insomnia1.5
Palpitations5.0
Tachycardia3.5
Extrasystoles ventricular1.5
Vasodilations1.0
Nausea3.0
Dry mouth1.5
Headache7.5
Asthenia2.0
Sweating1.0

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

Source: FDA drug label, NDA017849 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective November 15, 2019 (SPL set d810a15b-3e10-4f6c-a36e-8ddecbaba9c3), via openFDA; the full label on DailyMed

What do FAERS reports show?

1,823 reports list terbutaline among the medicines taken, each a report of something that happened, not proof the medicine caused it; 166 are coded as a death and 872 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, 4 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Dyspnoea423
  • Asthma (a use or a product term, not a reaction)378
  • Wheezing256
  • Pneumonia206
  • Cough204
  • Drug Ineffective (a use or a product term, not a reaction)151
  • Fatigue148
  • Loss Of Personal Independence In Daily Activities140
  • Therapeutic Product Effect Incomplete (a use or a product term, not a reaction)124
  • Sleep Disorder Due To A General Medical Condition118
  • Nasopharyngitis109
  • Malaise105
  • Dizziness (named in the label)102
  • Blood Pressure Increased100
  • Chest Discomfort100
  • Vomiting (named in the label)100
  • Nausea (named in the label)97
  • Headache (named in the label)88
  • Diarrhoea85
  • Full Blood Count Abnormal85
  • Heart Rate Increased83
  • Obstructive Airways Disorder82
  • Pyrexia82
  • Influenza79
  • Middle Insomnia79

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Terbutaline: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions